Carina Biotech

A cell therapy CRC company

Carina Biotech are an Australian biotech company researching and developing chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers, including paediatric and rare cancers.

Carina currently have three core technologies that they are marketing including:

  • CAR-T cells that attack atypical solid cancer antigens
  • A gel formulation to more effectively deliver CAR-T cells to solid tumour sites
  • A genetic homing signal to attract CAR-T cells to solid tumours
carinabiotech.com

Carina Biotech